OCS
Oculis Holding AG
NASDAQ · Healthcare · Biotechnology · CH
$7.32
+0.41%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- 0.01x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- -0.03x
Liquidity & coverage
- Current ratio
- 8.35x
- Quick ratio
- 8.35x
- Cash ratio
- 0.00x
- Interest coverage
- -93.99x
- EBITDA / interest
- -84.47x
- Working capital
- $249.1M
Cash & dividend
- FCF / debt
- -25.97x
- Cash flow / debt
- -25.90x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026